NASDAQ RESUMED AT 10:25 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:21 AM
NASDAQ RESUMED AT 09:54 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:49 AM
NASDAQ RESUMED AT 09:49 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:43 AM
NASDAQ RESUMED AT 09:37 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:35 AM
BeyondSpring triples on positive results for lung cancer drug
U.S. STOCKS ON THE MOVE-Zymergen, Robinhood, Tellurian, Alteryx
BeyondSpring Inc reports results for the quarter ended in March - Earnings Summary
Brief: BeyondSpring Announces First Quarter 2021 Financial Results And Provides A Corporate Update
BeyondSpring Inc expected to post a loss of 54 cents a share - Earnings Preview
BeyondSpring Inc expected to post a loss of 54 cents a share - Earnings Preview
Brief: BeyondSpring Announces Final Positive Data From The Protective-1 Phase 3 CIN Program Of Plinabulin As A Single Agent Compared To Pegfilgrastim At ASCO meeting
BeyondSpring Inc expected to post a loss of 54 cents a share - Earnings Preview
Brief: Beyondspring Announces Three Presentations Highlighting Positive Clinical Outcome Data From The Phase 3 Program Of Plinabulin
Brief: Beyondspring Announces First Patient Dosed In A Triple Combination Study To Treat Advanced Solid Tumors
BeyondSpring: Up as drug for chemo-induced condition gets priority review tag